Condition: SLE; Drug · Sponsor: Kangpu Biopharmaceuticals, Ltd.
Study Title A phase 1b/2a multicenter, randomized, double-blind, placebo-controlled study to assess the safety and tolerability, pharmacokinetics and preliminary efficacy of KPG-818 in patients with mild to moderate systemic lupus erythematosus
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Anniston Medical Clinic | Anniston, Alabama, United States | — |
| University of Alabama - Birmingham | Birmingham, Alabama, United States | — |
| Clinical Research of West Florida, Inc. | Clearwater, Florida, United States | — |
| Hope Clinical Trials, Inc. | Coral Gables, Florida, United States | — |
| JY Research Institute Inc | Cutler Bay, Florida, United States | — |
| OSIS Clinical Research | Hollywood, Florida, United States | — |
| SouthCoast Research Center Inc | Miami, Florida, United States | — |
| D & H National Research Centers | Miami, Florida, United States | — |
| Charisma Medical and Research Center | Miami Lakes, Florida, United States | — |
| San Marcus Research Clinic | Miami Lakes, Florida, United States | — |
| Omega Research MetroWest LLC | Orlando, Florida, United States | — |
| Clinical Research of West Florida | Tampa, Florida, United States | — |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04643067